Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for O25525

Entry ID Method Resolution Chain Position Source
AF-O25525-F1 Predicted AlphaFoldDB

No variants for O25525

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for O25525

No associated diseases with O25525

2 regional properties for O25525

Type Name Position InterPro Accession
domain IMP dehydrogenase/GMP reductase 6 - 317 IPR001093
conserved_site IMP dehydrogenase / GMP reductase, conserved site 166 - 178 IPR015875

Functions

Description
EC Number 1.7.1.7 With NAD(+) or NADP(+) as acceptor
Subcellular Localization
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
GMP reductase complex An oxidoreductase complex which is capable of GMP reductase activity. It catalyses the irreversible reaction: GMP + 2 H(+) + NADPH => IMP + NADP(+) + NH(4)(+).

1 GO annotations of molecular function

Name Definition
GMP reductase activity Catalysis of the reaction: IMP + NADP(+) + NH(4)(+) = GMP + 2 H(+) + NADPH.

1 GO annotations of biological process

Name Definition
purine nucleotide metabolic process The chemical reactions and pathways involving a purine nucleotide, a compound consisting of nucleoside (a purine base linked to a deoxyribose or ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MSLKVFDYED VQLIPNKCIV NSRSECDTTV ILGKHAFKMP IVPANMQTII NESIAEFLAE
70 80 90 100 110 120
NGYFYIMHRF DGAARIPFVK KMKKRQWISS ISVGVKKEEC LFVEELAKQG LAPDYITIDI
130 140 150 160 170 180
AHGHSNSVIE MIQRIKTHLP ETFVIAGNVG TPEAVRELEN AGADATKVGI GPGKVCITKI
190 200 210 220 230 240
KTGFGTGGWQ LAALRWCAKA ARKPIIADGG IRTHGDIVKS IRFGATMVMI GSLFAGHEES
250 260 270 280 290 300
SGETKIENGI AYKEYFGSAS EFQKGEKKNI EGKKIWIQHK GSLKDTLVEM HQDLQSSISY
310 320
AGGRDLEAIR KVDYVIVKNS IFNGDAI